corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Polí­ticas Farmacêuticas: a Serviçodos Interesses da Saúde?

By José Augusto Cabral Barros
2004

A REGULAMENTAÇÃO FARMACÊUTICA NA UE E NO PLANO INTERNACIONAL


Em função do adequado entendimento dos objetivos previstos no presente Projeto, faz-se necessário explicitar o que se entende por regulamentação farmacêutica. Trata-se do conjunto de normas estabelecidas pela autoridade sanitária de cada país e que devem nortear, no âmbito das definições da política de medicamentos, o comportamento de todos os agentes que fazem parte do setor farmacêutico e do conjunto de fatores que interferem no mesmo. A expressão mais evidente dessa regulamentação se dá na legislação sobre medicamentos.

 

Next Section:
A harmonização da regulamentacão farmacêutica na União Européia

Previous Section:
A EMEA – breve histórico

Books homepage

Políticas Farmaceuticas homepage

 

Comments

Our members can see and make comments on this page.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others. The contents of this page are the author's views and do not necessarily reflect the position of Healthy Skepticism or other members of Healthy Skepticism.

Please log in to access sharing tools.

Announcements

PharmedOut’s annual conference: Missing The Target: When Practitioners Harm More Than Heal

No Free Lunch is merging with Healthy Skepticism

Conference program: Pharma Knows Best? Managing Medical Knowledge

Prescrire’s proposals for France’s national conference on medicines policy

Pharmed Out Conference ‘Pharma Knows Best? Managing Medical Knowledge’

More announcements

What's new on this site




Books homepage

Politicas Farmaceuticas homepage

Next Section:
A harmonização da regulamentacão farmacêutica na União Européia

Previous Section:
A EMEA – breve histórico






Cases of wilful misrepresentation are a rarity in medical advertising. For every advertisement in which nonexistent doctors are called on to testify or deliberately irrelevant references are bunched up in [fine print], you will find a hundred or more whose greatest offenses are unquestioning enthusiasm and the skill to communicate it.

The best defence the physician can muster against this kind of advertising is a healthy skepticism and a willingness, not always apparent in the past, to do his homework. He must cultivate a flair for spotting the logical loophole, the invalid clinical trial, the unreliable or meaningless testimonial, the unneeded improvement and the unlikely claim. Above all, he must develop greater resistance to the lure of the fashionable and the new.
- Pierre R. Garai (advertising executive) 1963